A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Clinical trial NCT03293992 · COMPLETED
Trial details
- NCT number
- NCT03293992
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-10
- Primary completion
- 2017-12-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.